Literature DB >> 28076808

Spatiotemporal Modeling of Triggering and Amplifying Pathways in GLP-1 Secreting Intestinal L Cells.

Alessia Tagliavini1, Morten Gram Pedersen2.   

Abstract

Glucagon-like peptide 1 (GLP-1) is secreted by intestinal L-cells, and augments glucose-induced insulin secretion, thus playing an important role in glucose control. The stimulus-secretion pathway in L-cells is still incompletely understood and a topic of debate. It is known that GLP-1 secreting cells can sense glucose to promote electrical activity either by the electrogenic sodium-glucose cotransporter SGLT1, or by closure of ATP-sensitive potassium channels after glucose metabolism. Glucose also has an effect on GLP-1 secretion downstream of electrical activity. An important aspect to take into account is the spatial organization of the cell. Indeed, the glucose transporter GLUT2 is located at the basolateral, vascular side, while SGLT1 is exposed to luminal glucose at the apical side of the cell, suggesting that the two types of transporters play different roles in glucose sensing. Here, we extend our recent model of electrical activity in primary L-cells to include spatiotemporal glucose and Ca2+ dynamics, and GLP-1 secretion. The model confirmed that glucose transportation into the cell through SGLT1 cotransporters can induce Ca2+ influx and release of GLP-1 as a result of electrical activity, while glucose metabolism alone is insufficient to depolarize the cell and evoke GLP-1 secretion in the model, suggesting a crucial role for SGLT1 in triggering GLP-1 release in agreement with experimental studies. We suggest a secondary, but participating, role of GLUT2 and glucose metabolism for GLP-1 secretion via an amplifying pathway that increases the secretion rate at a given Ca2+ level.
Copyright © 2017 Biophysical Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28076808      PMCID: PMC5232896          DOI: 10.1016/j.bpj.2016.11.3199

Source DB:  PubMed          Journal:  Biophys J        ISSN: 0006-3495            Impact factor:   4.033


  33 in total

1.  Electrogenic properties of the cloned Na+/glucose cotransporter: II. A transport model under nonrapid equilibrium conditions.

Authors:  L Parent; S Supplisson; D D Loo; E M Wright
Journal:  J Membr Biol       Date:  1992-01       Impact factor: 1.843

2.  Model of beta-cell mitochondrial calcium handling and electrical activity. I. Cytoplasmic variables.

Authors:  G Magnus; J Keizer
Journal:  Am J Physiol       Date:  1998-04

3.  Analysis of upstream glucokinase promoter activity in transgenic mice and identification of glucokinase in rare neuroendocrine cells in the brain and gut.

Authors:  T L Jetton; Y Liang; C C Pettepher; E C Zimmerman; F G Cox; K Horvath; F M Matschinsky; M A Magnuson
Journal:  J Biol Chem       Date:  1994-02-04       Impact factor: 5.157

4.  Activation of sodium-glucose cotransporter 1 ameliorates hyperglycemia by mediating incretin secretion in mice.

Authors:  Ryuichi Moriya; Takashi Shirakura; Junko Ito; Satoshi Mashiko; Toru Seo
Journal:  Am J Physiol Endocrinol Metab       Date:  2009-10-06       Impact factor: 4.310

5.  Glucose-sensing in glucagon-like peptide-1-secreting cells.

Authors:  Frank Reimann; Fiona M Gribble
Journal:  Diabetes       Date:  2002-09       Impact factor: 9.461

6.  Na(+)-D-glucose cotransporter SGLT1 is pivotal for intestinal glucose absorption and glucose-dependent incretin secretion.

Authors:  Valentin Gorboulev; Annette Schürmann; Volker Vallon; Helmut Kipp; Alexander Jaschke; Dirk Klessen; Alexandra Friedrich; Stephan Scherneck; Timo Rieg; Robyn Cunard; Maike Veyhl-Wichmann; Aruna Srinivasan; Daniela Balen; Davorka Breljak; Rexhep Rexhepaj; Helen E Parker; Fiona M Gribble; Frank Reimann; Florian Lang; Stefan Wiese; Ivan Sabolic; Michael Sendtner; Hermann Koepsell
Journal:  Diabetes       Date:  2011-11-28       Impact factor: 9.461

7.  Mathematical modeling of heterogeneous electrophysiological responses in human β-cells.

Authors:  Michela Riz; Matthias Braun; Morten Gram Pedersen
Journal:  PLoS Comput Biol       Date:  2014-01-02       Impact factor: 4.475

Review 8.  RD Lawrence Lecture 2008: Targeting GLP-1 release as a potential strategy for the therapy of Type 2 diabetes.

Authors:  F M Gribble
Journal:  Diabet Med       Date:  2008-08       Impact factor: 4.359

9.  Generation of L cells in mouse and human small intestine organoids.

Authors:  Natalia Petersen; Frank Reimann; Sina Bartfeld; Henner F Farin; Femke C Ringnalda; Robert G J Vries; Stieneke van den Brink; Hans Clevers; Fiona M Gribble; Eelco J P de Koning
Journal:  Diabetes       Date:  2013-10-15       Impact factor: 9.461

10.  Small is fast: astrocytic glucose and lactate metabolism at cellular resolution.

Authors:  L F Barros; A San Martín; T Sotelo-Hitschfeld; R Lerchundi; I Fernández-Moncada; I Ruminot; R Gutiérrez; R Valdebenito; S Ceballo; K Alegría; F Baeza-Lehnert; D Espinoza
Journal:  Front Cell Neurosci       Date:  2013-03-22       Impact factor: 5.505

View more
  4 in total

Review 1.  Mechanisms of the amplifying pathway of insulin secretion in the β cell.

Authors:  Michael A Kalwat; Melanie H Cobb
Journal:  Pharmacol Ther       Date:  2017-05-18       Impact factor: 12.310

2.  3-Deoxyglucosone interferes with insulin signaling and attenuates insulin action on glucose-induced GLP-1 secretion in the enteroendocrine L cell line STC-1.

Authors:  Xiudao Song; Liang Zhou; Heng Xu; Fei Wang; Guoqiang Liang; Lurong Zhang; Fei Huang; Guorong Jiang
Journal:  Mol Biol Rep       Date:  2019-06-21       Impact factor: 2.316

3.  Optogenetic Analysis of Depolarization-Dependent Glucagonlike Peptide-1 Release.

Authors:  Catalin Chimerel; Cristian Riccio; Keir Murison; Fiona M Gribble; Frank Reimann
Journal:  Endocrinology       Date:  2017-10-01       Impact factor: 4.736

4.  Laminarin counteracts diet-induced obesity associated with glucagon-like peptide-1 secretion.

Authors:  Liusong Yang; Lina Wang; Canjun Zhu; Junguo Wu; Yexian Yuan; Lulu Yu; Yaqiong Xu; Jingren Xu; Tao Wang; Zhengrui Liao; Songbo Wang; Xiaotong Zhu; Ping Gao; Yongliang Zhang; Xiuqi Wang; Qingyan Jiang; Gang Shu
Journal:  Oncotarget       Date:  2017-08-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.